Pharmaceuticals

The Rise Of Surge In Epilepsy Cases Ignites Growth In The Epilepsy Drug Is Influencing The Prescription Drugs Market

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Prescription Drugs Market In 2026 And 2030?

The prescription drugs market size has experienced substantial growth in recent years. Its valuation is expected to rise from $1430.3 billion in 2025 to $1586.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.9%. This past growth can be attributed to several factors including the expansion of pharmaceutical manufacturing capabilities, the increasing occurrence of chronic diseases, the development of branded drug portfolios, a rise in healthcare expenditure, and the wider distribution of drugs in hospitals.

The prescription drugs market is poised for significant expansion over the next few years. It is expected to reach a size of $2368.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. This anticipated growth is driven by several factors, including an increasing demand for cost-effective generic medications, the rising adoption of biosimilars, the broadening use of digital prescription platforms, a growing emphasis on personalized drug therapies, and enhanced regulatory harmonization across different markets. Key trends identified for this period encompass the increased uptake of specialty prescription drugs, a rising demand for generic drug alternatives, a greater focus on managing chronic diseases, the expansion of biologic and biosimilar treatments, and a strengthened regulatory oversight concerning drug safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20597&type=smp

What Key Drivers Are Fueling The Growth Of The Prescription Drugs Market?

The expanding volume of drug production is anticipated to drive future growth in the prescription drug market. This production involves a systematic procedure for creating pharmaceutical items, covering their development, testing, and packaging to ensure they are high-quality, safe, and efficacious. Elevating drug production is vital for meeting the escalating worldwide need for medicines, tackling public health crises, and guaranteeing that treatments for various medical conditions are accessible without delay. Enhanced drug manufacturing can lead to improved availability, greater affordability, and increased innovation within the prescription drug market, ultimately benefiting patients and the broader healthcare system by facilitating access to crucial medications and fostering better health outcomes. For example, as reported in October 2025 by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based organization representing the pharmaceutical sector, the European pharmaceutical industry saw significant output growth, moving from $438 billion (€405,701 million) in 2023 to $475 billion (€440,000 million) in 2024. Hence, an increase in drug production will undoubtedly fuel the advancement of the prescription drug market.

How Is The Prescription Drugs Market Segmented Across Different Segment Categories?

The prescription drugs market covered in this report is segmented –

1) By Type: Branded, Generics

2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration

3) By Therapy Area: Oncology, Immunology, Ophthalmology, Respiratory, Dermatology, Gastroenterology, Urology, Gynecology, Endocrinology, Other Therapy Areas

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Branded: Innovative Drugs, Patented Drugs, Blockbuster Drugs, Over-the-Counter (OTC) Prescription Drugs, Biosimilars, Specialty Drugs, Orphan Drugs, Combination Drugs

2) By Generics: Small Molecule Generics, Generic Biologics, Over-the-Counter (OTC) Generics, Authorized Generics, Generic Combination Drugs, High-Volume Generics, Generic Versions Of Blockbuster Drugs

Which Trends Are Impacting The Progress Of The Prescription Drugs Market?

Leading companies within the prescription drug market are developing alternatives to Victoza (liraglutide) or similar GLP-1 receptor agonist therapies, with the goal of offering enhanced options for managing type 2 diabetes. Victoza is a brand-name prescription medication that contains liraglutide, an active ingredient that functions as a glucagon-like peptide-1 (GLP-1) receptor agonist. Its primary use is in managing type 2 diabetes for adults and children aged 10 years and older. For instance, in June 2024, Teva, an Israel-based company, launched an authorized generic of Victoza (liraglutide injection 1.8 mg). This provides a more affordable alternative while maintaining the same formulation, efficacy, and quality as the original branded product. This launch aims to improve patient access to essential diabetes treatments, by offering cost-effective solutions for managing type 2 diabetes and reducing the cardiovascular risks associated with the condition.

Which Organizations Play A Role In The Prescription Drugs Market Landscape?

Major companies operating in the prescription drugs market are Pfizer Inc., Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Allergan plc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited

Get The Full Prescription Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/prescription-drugs-global-market-report

Which Region Is The Largest In The Prescription Drugs Market?

North America was the largest region in the prescription drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Prescription Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/prescription-drugs-global-market-report

Browse Through More Reports Similar to the Global Prescription Drugs Market 2026, By The Business Research Company

Pancreatic Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Breast Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Lung Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795